In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
As "Spamalot" returns to the Hollywood Pantages, Eric Idle says of absurdist comedy, "these are the sort of times when we need it." ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results